Stay updated on Elsubrutinib & Upadacitinib in SLE Clinical Trial
Sign up to get notified when there's something new on the Elsubrutinib & Upadacitinib in SLE Clinical Trial page.

Latest updates to the Elsubrutinib & Upadacitinib in SLE Clinical Trial page
- Check4 days agoChange DetectedA new site revision (v3.4.1) has been added to the history, replacing the previous revision (v3.4.0).SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check13 days agoChange DetectedThe history page adds a Show glossary option and color-coded highlights for additions and deletions. It also updates the revision note to v3.4.0 and removes 'No FEAR Act Data'.SummaryDifference0.6%

- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedA new revision label v3.3.4 was added to the history and the older label v3.3.3 was removed.SummaryDifference0.1%

- Check49 days agoChange DetectedThe page history now includes a new entry: Revision: v3.3.3. The HHS Vulnerability Disclosure and the Revision: v3.3.2 entries were removed.SummaryDifference0.1%

- Check70 days agoChange DetectedThe page revision label was updated from v3.3.1 to v3.3.2 on the Record History page, with no changes to study data or content. No significant content updates were observed; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check77 days agoChange DetectedIn the record history, the revision is updated from v3.2.0 to v3.3.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Elsubrutinib & Upadacitinib in SLE Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Elsubrutinib & Upadacitinib in SLE Clinical Trial page.